%0 Journal Article %T Surgical treatment of atrial fibrillation in mitral valve surgery: a narrative review. %A Zou Y %A Yang N %A Ding F %A Wang Y %A Mei J %A Jiang Z %J J Thorac Dis %V 16 %N 5 %D 2024 May 31 %M 38883625 %F 3.005 %R 10.21037/jtd-23-1984 %X UNASSIGNED: Atrial fibrillation (AF) is one of the most common arrhythmias in clinical practice, which leads to cardiac decompensation, cardiovascular and cerebrovascular infarction, and other thromboembolic diseases. AF is one of the most common comorbidities of valvular heart disease, especially in mitral valve disease. At the time of their mitral valve surgery, 20-42% of patients have AF. It is beneficial to maintain postoperative sinus rhythm and minimize complications when AF surgery is performed concurrently with mitral valve surgery. This review describes the surgical management of AF in mitral valve surgery, including AF surgical route, surgical ablation technology and surgical approaches. The aim of this review is to enable more patients with AF to receive more appropriate and individualised treatment.
UNASSIGNED: A narrative review was conducted on the literature on PubMed, Embase including all relevant studies published until November 2023.
UNASSIGNED: This review focuses on the surgical management of AF during mitral valve surgery, including AF surgical route, surgical ablation technology and surgical approaches.
UNASSIGNED: Mitral valve surgery combined with AF surgery facilitates the maintenance of postoperative sinus rhythm in patients, reduces the risk of postoperative stroke, and improves survival. Advances in ablation technology have reduced the difficulty of the procedure, making it possible for more patients to undergo surgical ablation. In the future, it will be possible to tailor specific lesion sets and ablation modalities for individual patients. This would make surgical treatment of AF more effective and applicable to a larger population of patients with AF and mitral valve disease.